Over 4000 free audio and video lectures, seminars and teaching resources from Oxford University.
Skip to Content Skip to Navigation

Pharmaceutical Industry: Past, Present and Future

Is there a contradiction between profit-making and medical needs? How important are emerging markets for the future of pharmaceutical companies? And what are the ethical boundaries in the relationship between medical practitioners and pharma companies? This series of four lectures brings together leading figures in the pharmaceutical industry, health and business to look at the challenges of reconciling medical ethics and business in the 21st century against a backdrop of scientific and clinical developments and the expectations of patients.

This series was originally delivered as the 2009 Green Templeton Lectures entitled "Addicted to Big Pharma? Reconciling business, medical and ethical needs".

# Episode Title Description People Date
1 Is there a healthy future for Big Pharma? Dr Patterson will review the background to the pharmaceutical crisis and the different ways that companies are approaching the issues. The lecture will review both the research and development and business issues facing the industry and its investors. John Patterson, Sophia Tickell 04 Feb 2010
2 A Pharma perspective on healthcare needs and innovation in drug discovery The third Green Templeton Lecture 2009 explores how, by harnessing innovation to meet unmet medical needs, pharma companies can deliver significant value to patients, payers and shareholders. Patrick Vallance, Philip Bloomer 09 Jun 2009
3 Pharmaceutical Companies, Government and Society This lecture will explore, from a historical perspective, the relationship between an emerging pharmaceutical industry, the establishment of drug regulatory authorities, and - most recently - the development of health technology assessment. Sir Michael Rawlins 04 Jun 2009
4 Pharmaceutical Industry: Origin and Evolution Tilli Tansey, Professor of History of Modern Medical Sciences, University College London traces the evolution of the modern pharmaceutical industry from the mid nineteenth century to the final decades of the twentieth century. Tilli Tansey 19 May 2009